Skip to main
EHC

Encompass Health (EHC) Stock Forecast & Price Target

Encompass Health (EHC) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Encompass Health is well-positioned for future growth due to its focus on patients over 65, utilization of AI technology, strong balance sheet, and commitment to shareholder returns. Their emphasis on governance, quality outcomes, and patient safety, as well as experienced leadership and majority ownership of real estate, set them apart from competitors. While Medicare rates have seen decreases in recent years, the company's successful track record and potential for growth through investments and share repurchases mitigate potential risks.

Bears say

Encompass Health is facing potential challenges and risks in the inpatient rehab industry, including higher staffing costs and stricter reimbursement measures. Although their bed expansion strategy and partnerships have been successful, the company's highly-valued stock and potential limitations in the industry may hinder future growth opportunities. Additionally, the company's structural advantage in states with Certificate of Need regulations may not be enough to sustain its competitive edge in the long term.

Encompass Health (EHC) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Encompass Health (EHC) Forecast

Analysts have given Encompass Health (EHC) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Encompass Health (EHC) has a Strong Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $148.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $148.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Encompass Health (EHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.